Boldenone Undecylenate – EQUIPOISE
Equipoise (boldenone undecylenate) is an anabolic steroid sold under many other names like Boldenone, Ganabol and Ultragan. It is a synthetic anabolic steroid with a similar structure to testosterone.
The drug is only recommended for use in veterinary medicine. It has never been approved for use in humans in North America. Boldenone has come to fame mainly because of its abuse by bodybuilders.
Boldenone is like many other synthetic steroids. It is a potent anabolic agent at low doses and at high doses possesses both anabolic and androgenic properties. At low doses it can build the body when the diet is rich in calories. However, because it acts like an anabolic steroid, it can suppress the normal synthesis of testosterone in the testes. This can lead to impairment in spermatogenesis and decrease in libido.
When the drug is taken in high doses, it can also be converted into estrogen which can result in gynecomastia and also leads to water retention.
One other feature of Equipoise is that it can stimulate erythropoiesis (an increase in red blood cells). The mechanism for this effect has been associated with stimulation of the erythropoietin stimulating factor which then stimulates the bone marrow. The resulting increase in red blood cells, leads to more hemoglobin and a higher oxygen carrying capacity. Equipose, like other anabolic steroids can also cause changes in electrolytes because of its potent mineralocorticoid properties.
One major negative of Equipose, unlike its other analogues, is that it can stay in the body for a very long time. It has a prolonged half life because the drug does stay bound to tissues and is not broken down by the liver. Many reports indicate that the drug can be detected as long as 12-15 months after first use.
- Oily skin
- AcneHair loss
- Mood changes- aggression, paranoia, depression
- Water retention
- Swelling, edema
- High blood pressure
- Gynecomastia at high doses
- Testicular atrophy
- Possible liver cancer
- are pregnant
- have prostate or breast cancer
- have liver problems
- have a history of heart disease
- renal failure